305 related articles for article (PubMed ID: 27660666)
1.
Semaan A; van Ellen A; Meller S; Bergheim D; Branchi V; Lingohr P; Goltz D; Kalff JC; Kristiansen G; Matthaei H; Pantelis D; Dietrich D
Clin Epigenetics; 2016; 8():100. PubMed ID: 27660666
[TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation of
Branchi V; Schaefer P; Semaan A; Kania A; Lingohr P; Kalff JC; Schäfer N; Kristiansen G; Dietrich D; Matthaei H
Clin Epigenetics; 2016; 8():133. PubMed ID: 27999621
[TBL] [Abstract][Full Text] [Related]
3. Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study.
Bergheim J; Semaan A; Gevensleben H; Groening S; Knoblich A; Dietrich J; Weber J; Kalff JC; Bootz F; Kristiansen G; Dietrich D
Br J Cancer; 2018 May; 118(9):1217-1228. PubMed ID: 29610456
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous Analysis of SEPT9 Promoter Methylation Status, Micronuclei Frequency, and Folate-Related Gene Polymorphisms: The Potential for a Novel Blood-Based Colorectal Cancer Biomarker.
Ravegnini G; Zolezzi Moraga JM; Maffei F; Musti M; Zenesini C; Simeon V; Sammarini G; Festi D; Hrelia P; Angelini S
Int J Mol Sci; 2015 Dec; 16(12):28486-97. PubMed ID: 26633373
[TBL] [Abstract][Full Text] [Related]
5. Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population.
Lima AB; Dos Reis MB; Matsushita M; Dos Reis MT; de Oliveira MA; Reis RM; Guimarães DP
Cancer Med; 2023 Aug; 12(15):15854-15867. PubMed ID: 37338022
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Assessment of septin9 DNA Methylation for Colorectal Cancer Using Blood Detection: A Meta-Analysis.
Sun G; Meng J; Duan H; Zhang D; Tang Y
Pathol Oncol Res; 2019 Oct; 25(4):1525-1534. PubMed ID: 30488278
[TBL] [Abstract][Full Text] [Related]
7. The role of
Sun J; Fei F; Zhang M; Li Y; Zhang X; Zhu S; Zhang S
BMC Cancer; 2019 May; 19(1):450. PubMed ID: 31088406
[TBL] [Abstract][Full Text] [Related]
8. Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients.
de Vos L; Gevensleben H; Schröck A; Franzen A; Kristiansen G; Bootz F; Dietrich D
Clin Epigenetics; 2017; 9():125. PubMed ID: 29213339
[TBL] [Abstract][Full Text] [Related]
9. The SEPT9 gene methylation assay is capable of detecting colorectal adenoma in opportunistic screening.
Song L; Peng X; Li Y; Xiao W; Jia J; Dong C; Gong Y; Zhou G; Han X
Epigenomics; 2017 May; 9(5):599-610. PubMed ID: 28470092
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions.
Dietrich D; Jung M; Puetzer S; Leisse A; Holmes EE; Meller S; Uhl B; Schatz P; Ivascu C; Kristiansen G
PLoS One; 2013; 8(12):e84225. PubMed ID: 24386354
[TBL] [Abstract][Full Text] [Related]
11.
Laven-Law G; Kichenadasse G; Young GP; Symonds EL; Winter JM
Biomarkers; 2024 Jun; 29(4):194-204. PubMed ID: 38644767
[TBL] [Abstract][Full Text] [Related]
12. Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening.
Zhao G; Li H; Yang Z; Wang Z; Xu M; Xiong S; Li S; Wu X; Liu X; Wang Z; Zhu Y; Ma Y; Fei S; Zheng M
Cancer Med; 2019 Sep; 8(12):5619-5628. PubMed ID: 31407497
[TBL] [Abstract][Full Text] [Related]
13. High methylation of the SEPT9 gene in Chinese colorectal cancer patients.
Su XL; Wang YF; Li SJ; Zhang F; Cui HW
Genet Mol Res; 2014 Jan; 13(2):2513-20. PubMed ID: 24535900
[TBL] [Abstract][Full Text] [Related]
14. Treatment Response Monitoring in Patients with Advanced Malignancies Using Cell-Free SHOX2 and SEPT9 DNA Methylation in Blood: An Observational Prospective Study.
de Vos L; Jung M; Koerber RM; Bawden EG; Holderried TAW; Dietrich J; Bootz F; Brossart P; Kristiansen G; Dietrich D
J Mol Diagn; 2020 Jul; 22(7):920-933. PubMed ID: 32361006
[TBL] [Abstract][Full Text] [Related]
15. Detection of methylated septin 9 in tissue and plasma of colorectal patients with neoplasia and the relationship to the amount of circulating cell-free DNA.
Tóth K; Wasserkort R; Sipos F; Kalmár A; Wichmann B; Leiszter K; Valcz G; Juhász M; Miheller P; Patai ÁV; Tulassay Z; Molnár B
PLoS One; 2014; 9(12):e115415. PubMed ID: 25526039
[TBL] [Abstract][Full Text] [Related]
16. The performance of the mSEPT9 assay is influenced by algorithm, cancer stage and age, but not sex and cancer location.
Song L; Jia J; Yu H; Peng X; Xiao W; Gong Y; Zhou G; Han X; Li Y
J Cancer Res Clin Oncol; 2017 Jun; 143(6):1093-1101. PubMed ID: 28224298
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant, and malignant ascites.
Jung M; Pützer S; Gevensleben H; Meller S; Kristiansen G; Dietrich D
Clin Epigenetics; 2016; 8():24. PubMed ID: 26937257
[TBL] [Abstract][Full Text] [Related]
18. Detection of Colorectal Cancer Using a Simplified SEPT9 Gene Methylation Assay Is a Reliable Method for Opportunistic Screening.
Wu D; Zhou G; Jin P; Zhu J; Li S; Wu Q; Wang G; Sheng J; Wang J; Song L; Han X; Qian J
J Mol Diagn; 2016 Jul; 18(4):535-45. PubMed ID: 27133379
[TBL] [Abstract][Full Text] [Related]
19. Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island.
Wasserkort R; Kalmar A; Valcz G; Spisak S; Krispin M; Toth K; Tulassay Z; Sledziewski AZ; Molnar B
BMC Cancer; 2013 Aug; 13():398. PubMed ID: 23988185
[TBL] [Abstract][Full Text] [Related]
20. Circulating-tumour DNA methylation of HAND1 gene: a promising biomarker in early detection of colorectal cancer.
Shavali M; Moradi A; Tahmaseb M; Mohammadian K; Ganji SM
BMC Med Genomics; 2024 Apr; 17(1):117. PubMed ID: 38689296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]